Drugs / MediCabilis Cannabis sativa 50
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04997395 | Apr 2022 → Jan 2023 | long COVID-19 | Bod Australia | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MediCabilis Cannabis sativa 50 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04997395 ↗ |
| Route | Oral | “On commencing the oral medication” NCT04997395 ↗ |